top of page

Transplant Associated Disease EQA Programme

  • Cytomegalovirus Drug Resistance

  • Cytomegalovirus Whole Blood

  • Epstein-Barr virus DNA

  • Epstein-Barr virus Whole Blood

  • Human Cytomegalovirus DNA

  • Human Herpes Virus 6 DNA

  • JC virus DNA

  • Torque Teno Virus

  • Toxoplasma gondii DNA

  • Transplantation

Advances in molecular diagnostics have allowed accurate pathogen assessment prior to transplant and accurate quantitative monitoring, particularly of viral activity over time, after the transplant has been performed. This in turn allows early and accurate pre-emptive intervention and antiviral drug therapy. The range of QCMD EQA schemes within this area focus on those pathogens known to play a significant clinical role in transplant medicine. The general aim of this group of EQA schemes is to assess the ability of laboratories in the detection of the selected pathogen and where appropriate quantitative estimation is also evaluated.


bottom of page